Familial Multiple Endocrine Neoplasia Clinical Trials

• Studies of Inherited Diseases of Metabolism
  ClinicalTrials.gov Identifier: NCT00001345 - Recruiting
  Hypercalcemia; Hyperparathyroidism; Multiple Endocrine Neoplasia
  
• Psychosocial Aspects of MEN Syndromes
  ClinicalTrials.gov Identifier: NCT00501449 - Recruiting
  Multiple Endocrine Neoplasia
  
• Vandetanib in Treating Young Patients With Medullary Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00514046 - Recruiting
  Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
  
• Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00390325 - Recruiting
  Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
  
• Genetic Study of Patients With Inherited Urologic Malignancies
  ClinicalTrials.gov Identifier: NCT00019617 - Recruiting
  Birt Hogg Dube Syndrome; Kidney Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Von Hippel-Lindau Syndrome
  
• Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
  ClinicalTrials.gov Identifier: NCT00454363 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Neoplastic Syndrome
  
• Treatment of Zollinger-Ellison Syndrome With Prevacid
  ClinicalTrials.gov Identifier: NCT00204373 - Recruiting
  Zollinger-Ellison Syndrome; Multiple Endocrine Neoplasia
  
• Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00084357 - Active, not recruiting
  Pancreatic Cancer
  
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Prostate Cancer Prevention Study for Men with High Grade PIN (Prostatic Intraepithelial Neoplasia)
  ClinicalTrials.gov Identifier: NCT00106691 - Active, not recruiting
  Preneoplastic Conditions; Prostatic Intraepithelial Neoplasia
  
• Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049673 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Colorectal Neoplasia Screening With Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Centers: The CONCeRN Trial
  ClinicalTrials.gov Identifier: NCT00339950 - Active, not recruiting
  Colorectal Neoplasia
  
• Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS or ADH in Patients with Lobular Neoplasia of the Breast
  ClinicalTrials.gov Identifier: NCT00146536 - Recruiting
  Lobular neoplasia of the breast
  
• The Effect of Diflunisal on Familial Amyloidosis
  ClinicalTrials.gov Identifier: NCT00294671 - Recruiting
  Familial Amyloid Polyneuropathy; Familial Amyloidosis
  
• Study of ISIS 301012 in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
  ClinicalTrials.gov Identifier: NCT00281008 - Active, not recruiting
  Hypercholesterolemia, Familial
  
• Dose-Escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
  ClinicalTrials.gov Identifier: NCT00280995 - Active, not recruiting
  Hypercholesterolemia, Familial
  
• Effect of TAK-475 or Placebo co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00263081 - Active, not recruiting
  Hypercholesterolemia, Familial
  
• Endocrine Studies in Health and Disease
  ClinicalTrials.gov Identifier: NCT00006073 - Recruiting
  Endocrine Diseases
  
• A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00178113 - Active, not recruiting
  Prostatic Intraepithelial Neoplasia
  
• IL-1 Trap for Treatment of CIAS1 Associated Periodic Syndromes (CAPS)
  ClinicalTrials.gov Identifier: NCT00288704 - Active, not recruiting
  Familial Cold Autoinflammatory Syndrome; Familial Cold Urticaria; Muckle-Wells Syndrome; Genetic Diseases, Inborn
  
• Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
  ClinicalTrials.gov Identifier: NCT00465751 - Recruiting
  Metabolic Syndrome; Familial Hypertriglyceridemia; Familial Combined Hyperlipidemia
  
• Evaluation of Women with Endocrine and Reproductive-Related Conditions
  ClinicalTrials.gov Identifier: NCT00001850 - Recruiting
  Endocrine Disease; Infertility
  
• Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00582621 - Recruiting
  Lymphoma; Leukemia; Multiple Myeloma; Colon Cancer; Renal Cancer
  
• Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00515307 - Recruiting
  Hypercholesterolemia, Familial
  
• Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00477594 - Recruiting
  Familial Hypercholesterolemia
  
• Study of Lanreotide Autogel in Non-Functioning Entero-Pancreatic Endocrine Tumours
  ClinicalTrials.gov Identifier: NCT00353496 - Recruiting
  Endocrine Tumors
  
• Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
  ClinicalTrials.gov Identifier: NCT00005313 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia; Hyperlipidemia, Familial Combined
  
• Chemoprevention Trial in Familial Adenomatous Polyposis Coli Using EPA
  ClinicalTrials.gov Identifier: NCT00510692 - Active, not recruiting
  Familial Adenomatous Polyposis Coli; FAP
  
• Randomized Controlled Trial on Radiotherapy +/- Endocrine Therapy for PSA Failure After Radical Prostatectomy (JCOG0401)
  ClinicalTrials.gov Identifier: NCT00138008 - Recruiting
  Prostate Cancer
  
• Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
  ClinicalTrials.gov Identifier: NCT00475826 - Recruiting
  Heterozigous Familial Hypercholesterolemia
  
• Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals
  ClinicalTrials.gov Identifier: NCT00365235 - Recruiting
  Hyperlipidemia, Familial Combined; Coronary Disease
  
• Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00493545 - Recruiting
  Cervical Intraepithelial Neoplasia
  
• Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)
  ClinicalTrials.gov Identifier: NCT00525655 - Recruiting
  Familial Adenomatous Polyposis; Colorectal Cancer
  
• Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00511615 - Recruiting
  Cervical Intraepithelial Neoplasia
  
• Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
  ClinicalTrials.gov Identifier: NCT00248053 - Recruiting
  Familial Adenomatous Polyposis
  
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
  ClinicalTrials.gov Identifier: NCT00541736 - Recruiting
  Familial Hemiplegic Migraine
  
• Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
  ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
  Multiple Sclerosis
  
• Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00088855 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004903 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Bortezomib in Combination with CC-5013 in Patients with Relapsed/Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00153933 - Active, not recruiting
  Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
  
• PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
  refractory plasma cell neoplasm
  
• The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
  ClinicalTrials.gov Identifier: NCT00214851 - Recruiting
  Familial Cold Urticaria
  
• Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003490 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Genomic Dissection of a QTL Affecting the Lipid Profile
  ClinicalTrials.gov Identifier: NCT00064688 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity; Hyperlipidemia, Familial Combined
  
• Combination Chemotherapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002678 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Clinical and Genetic Studies of Familial Presenile Dementia with Neuronal Inclusion Bodies
  ClinicalTrials.gov Identifier: NCT00006176 - Recruiting
  Familial Dementia with Neuroserpin Inclusion Bodies; Nervous System Heredodegenerative Disorder
  
• A Chemoprevention Study of an Investigational Drug in Men with High Grade Prostate Intraepithelial Neoplasia (PIN)
  ClinicalTrials.gov Identifier: NCT00028353 - Completed
  Prostatic Intraepithelial Neoplasia
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Investigational Drug in Patients with Hypercholesterolemia or in Patients with Sitosterolemia
  ClinicalTrials.gov Identifier: NCT00092833 - Active, not recruiting
  Hypercholesterolemia, Familial; Lipid Metabolism, Inborn Errors
  
• Melphalan, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003954 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
  ClinicalTrials.gov Identifier: NCT00058071 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; neurotoxicity
  
• Safety of RG2077 in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
  Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
  
• Combination Chemotherapy With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00005834 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Phase III Randomized Study of Melphalan With or Without Holmium Ho 166 DOTMP Followed By Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00008229 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
  ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00048464 - Active, not recruiting
  Multiple Myeloma
  
• Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
  ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
  ovarian epithelial cancer
  
• Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients with Relapsed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00080405 - Active, not recruiting
  Multiple Myeloma
  
• Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00040937 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006219 - Active, not recruiting
  Multiple Myeloma
  
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00014508 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00095680 - Active, not recruiting
  Multiple Myeloma
  
• A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
  Multiple Sclerosis
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
  ClinicalTrials.gov Identifier: NCT00002630 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
  ClinicalTrials.gov Identifier: NCT00065351 - Active, not recruiting
  Multiple Myeloma
  
• Colorectal Cancer Screening Intervention in UWPN Clinics
  ClinicalTrials.gov Identifier: NCT00161460 - Recruiting
  Colorectal neoplasia
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
  
• VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
  Multiple Myeloma
  
• Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
  ClinicalTrials.gov Identifier: NCT00323440 - Not yet recruiting
  Familial Mediterranean Fever
  
• IL-1 Trap for Treatment of Familial Mediterranean Fever (FMF)
  ClinicalTrials.gov Identifier: NCT00582907 - Not yet recruiting
  Familial Mediterranean Fever
  
• Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00024466 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Auditory Function in Patients With and Without Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
  Multiple Sclerosis
  
• Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
  Multiple Sclerosis
  
• Study of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00087867 - Active, not recruiting
  Multiple Myeloma
  
• Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004158 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; stage I multiple myeloma; refractory plasma cell neoplasm
  
• PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin
  ClinicalTrials.gov Identifier: NCT00355615 - Active, not recruiting
  Familial Hypercholesterolemia
  
• Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
  Multiple Myeloma
  
• Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004165 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
  
• Evaluation of Safety and Immunogenicity of Co-Administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
  ClinicalTrials.gov Identifier: NCT00426361 - Active, not recruiting
  Papillomavirus Infections; Cervical Neoplasia
  
• Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002548 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00113919 - Active, not recruiting
  Multiple Myeloma
  
• Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
  Multiple Myeloma
  
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004088 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Evaluation of Patients with Endocrine-Related Conditions
  ClinicalTrials.gov Identifier: NCT00005664 - Recruiting
  Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; ...
  
• R115777 in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00021203 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Melphalan and Prednisone With or Without Bortezomib in Treating Older Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00109902 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma